Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSKP.L Regulatory News (SKP)

  • There is currently no data for SKP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Rule 8.3- Skyepharma PLC

8 Dec 2005 13:19

Fidelity International Ltd08 December 2005 FORM 8.3 DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE (Rule 8.3 of the City Code on Takeovers and Mergers) 1. KEY INFORMATION Name of person dealing (Note 1) FMR CORP. AND/OR ONE OR MORE OF ITS DIRECT OR INDIRECT SUBSIDIARIES AND FIDELITY INTERNATIONAL LIMITED AND/OR ONE OR MORE OF ITS DIRECT AND INDIRECT SUBSIDIARIES Company dealt in SKYEPHARMA PLC Class of relevant security ORDINARY SHARESto which the dealings being disclosed relate (Note 2) Date of dealing 07 DECEMBER 2005 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3) Long Short Number (%) Number (%) (1) Relevant securities 84,468,095 (11.21%)(2) Derivatives (other than options) (3) Options and agreements to purchase/sell Total 84,468,095 (11.21%) ADDITIONAL DIFFERENCE IN TOTAL HOLDINGS IS DUE TO NON-MARKET TRANSACTION (b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3) Class of relevant security: Long Short Number (%) Number (%) (1) Relevant securities (2) Derivatives (other than options) (3) Options and agreements to purchase/sell Total (c) Rights to subscribe (Note 3) Class of relevant security: Details 3. DEALINGS (Note 4) (a) Purchases and sales Purchase/sale Number of securities Price per unit (Note 5) SELL 441,015 0.5210 GBP/SHARE (b) Derivatives transactions (other than options) Product name, Long/short Number of securities Price per unit e.g. CFD (Note 6) (Note 7) (Note 5) (c) Options transactions in respect of existing securities(i) Writing, selling, purchasing or varying Product Writing, Number of Exercise Type, e.g. Expiry Option moneyname, selling, securities price American, date paid/e.g. purchasing, to which European received call varying etc. the option etc. per unit option relates (Note 5) (Note 7) (ii) Exercising Product name, e.g. Number of securities Exercise price per unit call option (Note 5) (d) Other dealings (including new securities)(Note 4) Nature of transaction Details Price per unit (Note 8) (if applicable) (Note 5) 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the persondisclosing and any other person relating to the voting rights of any relevantsecurities under any option referred to on this form or relating to the votingrights or future acquisition or disposal of any relevant securities to which anyderivative referred to on this form is referenced. If none, this should bestated. Is a Supplemental Form 8 attached? (Note 9) NO Date of disclosure 08 DECEMBER 2005 Contact name JAMES FOSTER Telephone number 01737 836713 If a connected EFM, name of N/Aofferee/offeror with which connected If a connected EFM, state nature of connection (Note 10) N/A Notes The Notes on Form 8.3 can be viewed on the Takeover Panel's website atwww.thetakeoverpanel.org.uk This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
28th Jan 20167:00 amRNSMundipharma appointed as partner for flutiform
21st Jan 201610:36 amRNSHolding(s) in Company
11th Jan 20167:00 amRNSPre-Close Update
6th Jan 201610:40 amRNSDirector/PDMR Shareholding
23rd Dec 20157:00 amRNSSKP-2076 to be partnered with Mundipharma
21st Dec 20152:47 pmRNSDirector Declaration
15th Dec 20153:36 pmRNSFavourable Resolution with FDA Relating to EXPAREL
14th Dec 201510:47 amRNSHolding(s) in Company
3rd Dec 201510:02 amRNSDirector/PDMR Shareholding
1st Dec 20155:26 pmRNSDirectorate Change
1st Dec 201510:01 amRNSHolding(s) in Company
27th Nov 20153:55 pmRNSHolding(s) in Company
26th Nov 20157:00 amRNSTrading Update and Capital Markets Meeting
18th Nov 20159:00 amRNSPresents at Jefferies Global Healthcare Conference
4th Nov 201510:52 amRNSDirector/PDMR Shareholding
5th Oct 20159:40 amRNSDirector/PDMR Shareholding
4th Sep 20159:24 amRNSDirector/PDMR Shareholding
1st Sep 201510:29 amRNSHolding(s) in Company
26th Aug 20157:00 amRNS2015 Interim Results
6th Aug 20157:00 amRNSNotice of Results
4th Aug 20153:36 pmRNSDirector/PDMR Shareholding
30th Jul 20152:11 pmRNSHolding(s) in Company
3rd Jul 201510:03 amRNSDirector/PDMR Shareholding
25th Jun 20157:00 amRNSInterim Results Pre-close Trading Update
2nd Jun 20153:03 pmRNSDirector/PDMR Shareholding
1st Jun 20159:00 amRNSPresenting at Jefferies 2015 Healthcare Conference
12th May 20154:26 pmRNSResult of AGM
12th May 20157:00 amRNSAGM Trading Update
11th May 201510:08 amRNSDirector/PDMR Shareholding
24th Apr 201510:27 amRNSDirector Declaration
10th Apr 20154:33 pmRNSAnnual Financial Report
2nd Apr 201512:17 pmRNSDirector/PDMR Shareholding
26th Mar 20154:59 pmRNSDirector/PDMR Shareholding
26th Mar 20154:34 pmRNSDirector/PDMR Shareholding
24th Mar 20157:00 amRNSFinal Results
20th Mar 20159:00 amRNSSkyepharma wins at PLC Awards
11th Mar 20159:49 amRNSHolding(s) in Company
4th Mar 201510:45 amRNSNotice of Results
3rd Mar 20152:58 pmRNSDirector/PDMR Shareholding
25th Feb 20154:14 pmRNSHolding(s) in Company
13th Feb 20157:00 amRNSEarly repayment of the CRC Finance facility
9th Feb 20154:26 pmRNSHolding(s) in Company
3rd Feb 20152:25 pmRNSDirector/PDMR Shareholding
28th Jan 20154:46 pmRNSHolding(s) in Company
14th Jan 20153:46 pmRNSHolding(s) in Company
12th Jan 20157:00 amRNSPre-close update
5th Jan 20155:38 pmRNSDirector/PDMR Shareholding
8th Dec 20142:13 pmRNSDirector/PDMR Shareholding
2nd Dec 20144:33 pmRNSDirector/PDMR Shareholding
1st Dec 20147:04 amRNSKyorin launches flutiform 120-puff version

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.